United States digital PCR market size reached US$ 1.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.0 Billion by 2032, exhibiting a growth rate (CAGR) of 22.20% during 2024-2032. The rising prevalence of genetic disorders and infectious diseases, which has increased the demand for accurate and sensitive diagnostic tools, is driving the market.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2023 |
Forecast Years
|
2024-2032 |
Historical Years
|
2018-2023
|
Market Size in 2023 | US$ 1.2 Billion |
Market Forecast in 2032 | US$ 7.0 Billion |
Market Growth Rate (2024-2032) | 22.20% |
Digital PCR (dPCR) is a precise and sensitive molecular biology technique used to quantify and analyze nucleic acids, such as DNA and RNA. Unlike traditional PCR, which amplifies DNA in a continuous manner, dPCR divides a sample into thousands of individual reactions, each occurring in separate compartments. This isolation allows for absolute quantification of target molecules, as opposed to relative quantification in conventional PCR. The sample is partitioned into numerous small volumes, and after amplification, the presence or absence of the target molecule in each compartment is assessed. By counting positive reactions, dPCR provides absolute quantification, making it highly accurate for applications like rare mutation detection, copy number variation analysis, and absolute quantification of gene expression. The digital nature of this method enhances sensitivity, robustness, and precision, making dPCR a valuable tool in various research and diagnostic applications.
The digital PCR market in the United States is experiencing robust growth, propelled by several key drivers that underscore its pivotal role in molecular diagnostics and life sciences research. Firstly, the escalating demand for precise and sensitive quantification of nucleic acids has fueled the adoption of dPCR technologies. Moreover, the growing focus on personalized medicine and targeted therapies has heightened the need for accurate and reliable nucleic acid analysis, further boosting the market. In addition to this, the advent of novel applications, such as liquid biopsy and rare mutation detection, has expanded the scope of dPCR, driving its market penetration. Furthermore, the rising prevalence of genetic disorders and infectious diseases has accentuated the importance of dPCR in clinical diagnostics, amplifying its market traction. Seamless integration with next-generation sequencing (NGS) and other omics technologies has also emerged as a synergistic factor propelling the dPCR market forward. Furthermore, strategic collaborations between industry stakeholders and academic institutions have facilitated technological advancements and product innovations, fostering market growth. Besides this, the increasing automation and digitization of laboratory processes, which have augmented the efficiency of dPCR workflows, contributing to its widespread adoption, is expected to drive the market in the United States during the forecast period.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2024-2032. Our report has categorized the market based on product type, technology, and application.
Product Type Insights:
The report has provided a detailed breakup and analysis of the market based on the product type. This includes digital PCR equipment, consumables and reagents, and software and services.
Technology Insights:
A detailed breakup and analysis of the market based on the technology have also been provided in the report. This includes droplet digital PCR and BEAMing digital PCR.
Application Insights:
The report has provided a detailed breakup and analysis of the market based on the application. This includes clinical diagnostics, forensics, research, and others.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include the Northeast, Midwest, South, and West.
The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Report Features | Details |
---|---|
Base Year of the Analysis | 2023 |
Historical Period | 2018-2023 |
Forecast Period | 2024-2032 |
Units | US$ Billion |
Scope of the Report | Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Product Types Covered | Digital PCR Equipment, Consumables and Reagents, Software and Services |
Technologies Covered | Droplet Digital PCR, BEAMing Digital PCR |
Applications Covered | Clinical Diagnostics, Forensics, Research, Others |
Regions Covered | Northeast, Midwest, South, West |
Customization Scope | 10% Free Customization |
Report Price and Purchase Option | Single User License: US$ 3699 Five User License: US$ 4699 Corporate License: US$ 5699 |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |